2,255 Shares in Revvity Inc. $RVTY Purchased by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC acquired a new position in Revvity Inc. (NYSE:RVTY) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,255 shares of the company’s stock, valued at approximately $218,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its position in Revvity by 3.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock worth $544,000 after purchasing an additional 187 shares during the last quarter. Ritholtz Wealth Management acquired a new position in shares of Revvity during the first quarter worth approximately $210,000. Amalgamated Bank raised its stake in Revvity by 1.0% during the 1st quarter. Amalgamated Bank now owns 23,777 shares of the company’s stock valued at $2,516,000 after acquiring an additional 227 shares in the last quarter. Family Legacy Financial Solutions LLC bought a new stake in Revvity during the 2nd quarter valued at $5,351,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Revvity by 11.1% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 13,415 shares of the company’s stock valued at $1,417,000 after acquiring an additional 1,343 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on RVTY shares. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Bank of America reduced their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Evercore ISI dropped their target price on Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a report on Tuesday. Barclays dropped their target price on Revvity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday, October 2nd. Finally, Stifel Nicolaus lowered their price target on Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a research report on Tuesday, July 29th. Ten analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.93.

Revvity Stock Performance

RVTY opened at $88.36 on Friday. The firm has a market cap of $10.26 billion, a PE ratio of 37.44, a P/E/G ratio of 3.06 and a beta of 0.98. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The business has a fifty day simple moving average of $88.08 and a 200-day simple moving average of $92.93. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $129.50.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The business had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.Revvity’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. As a group, equities analysts predict that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity’s dividend payout ratio (DPR) is 11.86%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.